Logo

Bio-Rad Acquires ProteOptics to Expand Proteomics Portfolio

Feb 27, 2006

NEW YORK, Feb. 27 (GenomeWeb News) - Bio-Rad said last week that it has acquired ProteOptics, an Israel-based maker of surface plasmon resonance technology.

 

Terms of the acquisition were not disclosed.

 

ProteOptics' technology involves the use of image analysis to track optical changes without the need of any molecular labeling in order to monitor biomolecular interactions, and is expected to expand Bio-Rad's proteomics' product offerings, Bio-Rad said.

Breaking News
The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.